Difference between revisions of "Journal Club"
Line 9: | Line 9: | ||
!scope="col" style="padding:.4em" | Paper title | !scope="col" style="padding:.4em" | Paper title | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/03/ | + | |style="padding:.4em;" rowspan=1|2023/03/14 |
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
|style="padding:.4em;"|23-9 | |style="padding:.4em;"|23-9 | ||
Line 16: | Line 16: | ||
[https://www.nature.com/articles/s41588-022-01141-9 Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment] | [https://www.nature.com/articles/s41588-022-01141-9 Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment] | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/ | + | |style="padding:.4em;" rowspan=1|2023/03/07 |
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
|style="padding:.4em;"|23-8 | |style="padding:.4em;"|23-8 | ||
Line 23: | Line 23: | ||
[https://www.biorxiv.org/content/10.1101/2022.08.05.502989v1 MetaTiME: Meta-components of the Tumor Immune Microenvironment] | [https://www.biorxiv.org/content/10.1101/2022.08.05.502989v1 MetaTiME: Meta-components of the Tumor Immune Microenvironment] | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/02/ | + | |style="padding:.4em;" rowspan=1|2023/02/28 |
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
|style="padding:.4em;"|23-7 | |style="padding:.4em;"|23-7 | ||
Line 30: | Line 30: | ||
[https://www.nature.com/articles/s41590-022-01262-7 Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy] | [https://www.nature.com/articles/s41590-022-01262-7 Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy] | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/02/ | + | |style="padding:.4em;" rowspan=1|2023/02/21 |
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
|style="padding:.4em;"|23-6 | |style="padding:.4em;"|23-6 | ||
Line 37: | Line 37: | ||
[https://www.biorxiv.org/content/10.1101/2022.03.16.484513v1 Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating T cells] | [https://www.biorxiv.org/content/10.1101/2022.03.16.484513v1 Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating T cells] | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/02/ | + | |style="padding:.4em;" rowspan=1|2023/02/14 |
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
|style="padding:.4em;"|23-5 | |style="padding:.4em;"|23-5 | ||
Line 84: | Line 84: | ||
!scope="col" style="padding:.4em" | Paper title | !scope="col" style="padding:.4em" | Paper title | ||
|- | |- | ||
− | |style="padding:.4em;" rowspan=1|2023/02/ | + | |style="padding:.4em;" rowspan=1|2023/02/14 |
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
|style="padding:.4em;"|23-5 | |style="padding:.4em;"|23-5 |
Revision as of 11:14, 18 January 2023
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2023/03/14 | Single-cell | 23-9 | G Koh | |
2023/03/07 | Single-cell | 23-8 | JW Yu |
MetaTiME: Meta-components of the Tumor Immune Microenvironment |
2023/02/28 | Single-cell | 23-7 | JH Cha | |
2023/02/21 | Single-cell | 23-6 | SB Baek | |
2023/02/14 | Single-cell | 23-5 | EJ Sung |
A T cell resilience model associated with response to immunotherapy in multiple tumor types |
2022/01/31 | Single-cell | 23-4 | IS Choi | |
2023/01/25 | Single-cell | 23-3 | G Koh | |
2023/01/17 | Single-cell | 23-2 | JW Yu |
Pan-cancer integrative histology-genomic analysis via multimodal deep learning |
2023/01/11 | Single-cell | 23-1 | JH Cha |
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2023/02/14 | Microbiome | 23-5 | NY Kim | |
2023/01/31 | Microbiome | 23-4 | SH Lee | |
2023/01/25 | Microbiome | 23-3 | SH Ahn |
Scalable power analysis and effect size exploration of microbiome community differences with Evident |
2023/01/17 | Microbiome | 23-2 | HJ Kim | |
2023/01/11 | Microbiome | 23-1 | JH Cha |
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2021/11/23 | Single-cell | 21-39 | IS Choi | |
2021/11/16 | Single-cell | 21-38 | SB Back | |
2021/11/09 | Single-cell | 21-37 | JH Cha | |
2021/11/02 | Single-cell | 21-36 | SB Baek |
Functional Inference of Gene Regulation using Single-Cell Multi-Omics |
2021/10/26 | Single-cell | 21-35 | IS Choi | |
2021/10/19 | Single-cell | 21-34 | JH Cha | |
2021/10/05 | Single-cell | 21-33 | JH Cha |
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma |
2021/09/28 | Single-cell | 21-32 | SB Baek | |
2021/09/14 | Single-cell | 21-31 | IS Choi | |
2021/09/07 | Single-cell | 21-30 | JH Cha |
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer |
2021/08/31 | Single-cell | 21-29 | IS Choi |
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma |
2021/08/24 | Single-cell | 21-28 | SB Baek |
Interpreting type 1 diabetes risk with genetics and single-cell epigenomics |
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2021/02/22 | Single-cell | 21-8 | IS Choi |
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity |
21-7 | JH Cha |
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy | ||
2021/02/15 | Single-cell | 21-6 | SB Baek | |
21-5 | IS Choi |
Trajectory-based differential expression analysis for single-cell sequencing data | ||
2021/02/08 | Single-cell | 21-4 | SB Baek |
Genetic determinants of co-accessible chromatin regions in activated T cells across humans |
21-3 | JH Cha |
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer | ||
2021/02/01 | Single-cell | 21-2 | JW Cho | |
21-1 | JW Cho |